Study Summary
This trial aims to develop two clinical tools to help high-risk youth make healthy choices by using a genetic malleability framing.
- Psychosis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 4 Secondary · Reporting Duration: 15 minutes
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
25 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 16 - 30 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Do I meet the criteria to participate in this experiment?
"This clinical research is recruiting 54 individuals aged 16-30 who currently have psychosis and fit into one of the three categories listed under atteneded positive symptoms. Furthermore, all interested candidates must be (or recently had been) participants in COPE." - Anonymous Online Contributor
Does the inclusion criteria for this research project include those aged sixty and above?
"This clinical study has particular requirements for qualified applicants; they must be between 16 and 30 years old. There are 116 trials specifically recruiting minors and 262 trials that cater to elderly patients." - Anonymous Online Contributor
What is the targeted cohort for this clinical research?
"Affirmative. The clinical trial website, clinicaltrials.gov, reports that the research is actively recruiting with 54 patients needing to be recruited from one medical centre. This study was first posted on November 16th 2020 and most recently updated June 6th 2022." - Anonymous Online Contributor
Is the research team actively seeking participants for this experiment?
"As confirmed by clinicaltrials.gov, this medical trial is actively in search of participants. The initial post was on the 16th November 2020 and it has since been revised at least once as of 6 June 2022." - Anonymous Online Contributor
What aims has this trial been designed to achieve?
"The primary focus of this 15-minute clinical trial is to measure Behavioral Intent towards Engaging in Treatment. Secondary outcomes include Anticipated Rejection and Discrimination from Others Due to Genetic Risk for Psychosis Development, which are both based on published scales (Link et al., 2015; Wahl, 1999). Additionally, an Implicit Association Test will be performed to assess participants' associations between 'Normal/Abnormal' and 'Changeable/Permanent'. As it is an exploratory R21 study, the investigators have constructed new measures as well." - Anonymous Online Contributor